Article
Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data
Rating:
0.0
Views:
70
Likes:
1
Library:
1
Sanofi's asthma drug Dupixent met all targets in a trial to treat "smoker's lung", potentially adding billions to the French drugmaker's growth prospects, but also underscoring a heavy reliance on its bestseller.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value